Foreign Investment In Sth Korean Pharma Markets

28 May 1995

South Korea has seen pharmaceutical sales expanding, reaching the equivalent in 1992 of 1.6% of the global market (compared with 3.3% of the UK and 2.3% of Canada). Its value in 1993 was $2.5 billion, making South Korea the 10th largest pharmaceutical industry in the world, according to a new report from Datamonitor, entitled Opportunities in Asian Pharmaceutical Markets.

At the beginning of 1994 there were 41 foreign companies involved in South Korean pharmaceutical operations. And firms already there are in negotiations with local companies, as the economy is now fully deregulated and foreign investors can hold 100% of local concerns.

Of the companies with bases in the country, 12 are US firms, 11 Japanese, five German, three from the Netherlands, two French and a further eight from other countries, the Datamonitor report notes.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight